Citigroup’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107K Buy
7,616
+6,281
+470% +$90.9K ﹤0.01% 4259
2025
Q4
$20.6K Sell
1,335
-257
-16% -$3.02K ﹤0.01% 4863
2025
Q3
$13.7K Sell
1,592
-10,551
-87% -$86.2K ﹤0.01% 4931
2025
Q2
$121K Buy
12,143
+11,652
+2,373% +$397K ﹤0.01% 4319
2025
Q1
$43.1K Buy
491
+28
+6% +$2.46K ﹤0.01% 4915
2024
Q4
$43K Sell
463
-6,206
-93% -$535K ﹤0.01% 5125
2024
Q3
$488K Buy
6,669
+6,568
+6,503% +$424K ﹤0.01% 3743
2024
Q2
$5.88K Buy
101
+28
+38% +$18.6K ﹤0.01% 5235
2024
Q1
$75.3K Buy
73
+13
+22% +$9.93K ﹤0.01% 4420
2023
Q4
$47.4K Buy
60
+54
+900% +$27.5K ﹤0.01% 4550
2023
Q3
$2.89K Sell
6
-89
-94% -$48.2K ﹤0.01% 4865
2023
Q2
$57K Buy
95
+88
+1,257% +$56.3K ﹤0.01% 4565
2023
Q1
$4.62K Sell
7
-3
-30% -$2.49K ﹤0.01% 4961
2022
Q4
$10.2K Sell
10
-5
-33% -$3.63K ﹤0.01% 4831
2022
Q3
$8K Sell
15
-16
-52% -$10.7K ﹤0.01% 5054
2022
Q2
$17K Sell
31
-10
-24% -$4.78K ﹤0.01% 5089
2022
Q1
$26K Sell
41
-58
-59% -$22.5K ﹤0.01% 5016
2021
Q4
$41K Buy
99
+66
+200% +$33.4K ﹤0.01% 5156
2021
Q3
$24K Buy
+33
New +$18.5K ﹤0.01% 5148

Other funds holding JBIO